Inventor · disambiguated record
Alexander Greenfield
Also filed as: GREENFIELD ALEXANDER · GREENFIELD ALEXANDER A · GREENFIELD ALEXANDER ALEXEI
13 granted patents·4 pending applications·90 citations·filing 1999–2008
89Inventor score
Top patents by PatentIndex Score
17 records- 0189US7256198B2Pyrimidoindolones and methods for using sameWYETH CORP·Filed 2005·Granted Aug 14, 2007·11 cites·29 claims
- 0289US6930131B2Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM)WYETH CORP·Filed 2003·Granted Aug 16, 2005·32 cites·16 claims
- 0385US6214877B12,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemiaFiled 1999·Granted Apr 10, 2001·27 cites·151 claims
- 0482US6765021B22,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemiaWYETH CORP·Filed 2002·Granted Jul 20, 2004·11 cites·6 claims
- 0574US7414051B2Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Aug 19, 2008·2 cites·16 claims
- 0670US7723329B2Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2006·Granted May 25, 2010·1 cites·22 claims
- 0770US6689904B2Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycineWYETH CORP·Filed 2002·Granted Feb 10, 2004·5 cites·9 claims
- 0860US2008280894A1DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDSWYETH CORP·Filed 2008·Application pending·0 cites
- 0957US2007270587A1Pyrimidoindolones and methods for using sameWYETH CORP·Filed 2007·Application pending·0 cites
- 1056US2008280893A1SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDSWYETH CORP·Filed 2008·Application pending·0 cites
- 1155US6451827B22,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemiaWYETH CORP·Filed 2001·Granted Sep 17, 2002·1 cites·24 claims
- 1254US7429582B2Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands and use thereof in the treatment of attention deficit disordersWYETH CORP·Filed 2007·Granted Sep 30, 2008·0 cites·16 claims
- 1351US7008636B22,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemiaWYETH CORP·Filed 2004·Granted Mar 7, 2006·0 cites·32 claims
- 1445US7790751B2Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2006·Granted Sep 7, 2010·0 cites·14 claims
- 1544US2007244179A1Dihydro[1,4]dioxino[2,3-e]indazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Application pending·0 cites
- 1641US6933322B2Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitusWYETH CORP·Filed 2003·Granted Aug 23, 2005·0 cites·21 claims
- 1739US6750364B2Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transportWYETH CORP·Filed 2002·Granted Jun 15, 2004·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →